Skip to main content
. 2016 Sep 26;14(5):4445–4453. doi: 10.3892/mmr.2016.5774

Figure 1.

Figure 1.

Expression of Rab5a in T/G HA-VSMCs treated in various manners. (A) The protein expression levels of Rab5a were determined by western blotting analysis following various treatments. GAPDH was used as a loading control. (B) The mRNA expression levels of Rab5a were determined by reverse transcription-quantitative polymerase chain reaction analysis following various treatments. The data were quantified and mRNA expression levels were determined relative to the expression of GAPDH. The data are presented as the mean ± standard deviation (**P<0.01 compared with the siC group.) si, siRNA; C, control; R, Rab5a; P, PDGF; PDGF, platelet-derived growth factor; T/G HA-VSMC, human aorta-vascular smooth muscle cell line.